Información del artículo
El Texto completo está disponible en PDF
Biblografía
[1.]
M. Vaqueiro, L. Mendarte, G. Rodríguez, A. Ruiz.
Uso de fármacos del sistema nervioso central en un centro sociosanitario.
Rev Esp Geriatr Gerontol, 36 (2001), pp. 28-31
[2.]
C.M. Hughes, K.L. Lapane, V. Mor, et al.
The impact of legislation on psychotropic drug use in nursing homes: a cross-national perspective.
J Am Geriatr Soc, 48 (2000), pp. 931-937
[3.]
J.H. Gurwitz, T.S. Field, J. Avorn, et al.
Incidence and preventability of adverse drug events in nursing homes.
Am J Med, 109 (2000), pp. 87-94
[4.]
B.W. Rovner, P.S. Geerman, L.J. Brant, et al.
Depression and mortality in nursing homes.
JAMA, 265 (1991), pp. 993-996
[5.]
L.L. Heston, J. Garrard, L. Makris, et al.
Inadequate treatment of depressed nursing home elderly.
J Am Geriatr Soc, 40 (1992), pp. 1117-1122
[6.]
M.H. Beers, J.G. Ouslander, I. Rollingher, et al.
Explicit criteria for determining inappropiate medication use in nursing home residents.
Arch Intern Med, 151 (1991), pp. 1825-1832
[7.]
I. De la Serna.
Tratamientos psicofarmacológicos.
Manual de psicogeriatría clínica, pp. 247-293
[8.]
S. Madhusoodanan, P. Suresh, R. Brenner, et al.
Experience with the atypical antipsychotics-risperidone and olanzapine in the elderly.
Ann Clin Psychiatry, 11 (1999), pp. 113-118
[9.]
J.M. Evans, D.S. Chutka, K.V. Fleming, et al.
Medical care of nursing home residents.
Mayo Clin Proc, 70 (1995), pp. 694-702
Copyright © 2001. Sociedad Española de Geriatría y Gerontología
